42 research outputs found
A Hypermorphic Missense Mutation in PLCG2, Encoding Phospholipase CĪ³2, Causes a Dominantly Inherited Autoinflammatory Disease with Immunodeficiency
Whole-exome sequencing was performed in a family affected by dominantly inherited inflammatory disease characterized by recurrent blistering skin lesions, bronchiolitis, arthralgia, ocular inflammation, enterocolitis, absence of autoantibodies, and mild immunodeficiency. Exome data from three samples, including the affected father and daughter and unaffected mother, were filtered for the exclusion of reported variants, along with benign variants, as determined by PolyPhen-2. A total of eight transcripts were identified as possible candidate genes. We confirmed a variant, c.2120C>A (p.Ser707Tyr), within PLCG2 as the only de novo variant that was present in two affected family members and not present in four unaffected members. PLCG2 encodes phospholipase CĪ³2 (PLCĪ³2), an enzyme with a critical regulatory role in various immune and inflammatory pathways. The p.Ser707Tyr substitution is located in an autoinhibitory SH2 domain that is crucial for PLCĪ³2 activation. Overexpression of the altered p.Ser707Tyr protein and exĀ vivo experiments using affected individualsā leukocytes showed clearly enhanced PLCĪ³2 activity, suggesting increased intracellular signaling in the PLCĪ³2-mediated pathway. Recently, our laboratory identified in individuals with cold-induced urticaria and immune dysregulation PLCG2 exon-skipping mutations resulting in protein products with constitutive phospholipase activity but with reduced intracellular signaling at physiological temperatures. In contrast, the p.Ser707Tyr substitution in PLCĪ³2 causes a distinct inflammatory phenotype that is not provoked by cold temperatures and that has different end-organ involvement and increased intracellular signaling at physiological temperatures. Our results highlight the utility of exome-sequencing technology in finding causal mutations in nuclear families with dominantly inherited traits otherwise intractable by linkage analysis
TMEM106B is a genetic modifier of frontotemporal lobar degeneration with C9orf72 hexanucleotide repeat expansions
Hexanucleotide repeat expansions in chromosome 9 open reading frame 72 (C9orf72) have recently been linked to frontotemporal lobar degeneration (FTLD) and amyotrophic lateral sclerosis, and may be the most common genetic cause of both neurodegenerative diseases. Genetic variants at TMEM106B influence risk for the most common neuropathological subtype of FTLD, characterized by inclusions of TAR DNA-binding protein of 43 kDa (FTLD-TDP). Previous reports have shown that TMEM106B is a genetic modifier of FTLD-TDP caused by progranulin (GRN) mutations, with the major (risk) allele of rs1990622 associating with earlier age at onset of disease. Here, we report that rs1990622 genotype affects age at death in a single-site discovery cohort of FTLD patients with C9orf72 expansions (n = 14), with the major allele correlated with later age at death (p = 0.024). We replicate this modifier effect in a 30-site international neuropathological cohort of FTLD-TDP patients with C9orf72 expansions (n = 75), again finding that the major allele associates with later age at death (p = 0.016), as well as later age at onset (p = 0.019). In contrast, TMEM106B genotype does not affect age at onset or death in 241 FTLD-TDP cases negative for GRN mutations or C9orf72 expansions. Thus, TMEM106B is a genetic modifier of FTLD with C9orf72 expansions. Intriguingly, the genotype that confers increased risk for developing FTLD-TDP (major, or T, allele of rs1990622) is associated with later age at onset and death in C9orf72 expansion carriers, providing an example of sign epistasis in human neurodegenerative disease
Finishing the euchromatic sequence of the human genome
The sequence of the human genome encodes the genetic instructions for human physiology, as well as rich information about human evolution. In 2001, the International Human Genome Sequencing Consortium reported a draft sequence of the euchromatic portion of the human genome. Since then, the international collaboration has worked to convert this draft into a genome sequence with high accuracy and nearly complete coverage. Here, we report the result of this finishing process. The current genome sequence (Build 35) contains 2.85 billion nucleotides interrupted by only 341 gaps. It covers ā¼99% of the euchromatic genome and is accurate to an error rate of ā¼1 event per 100,000 bases. Many of the remaining euchromatic gaps are associated with segmental duplications and will require focused work with new methods. The near-complete sequence, the first for a vertebrate, greatly improves the precision of biological analyses of the human genome including studies of gene number, birth and death. Notably, the human enome seems to encode only 20,000-25,000 protein-coding genes. The genome sequence reported here should serve as a firm foundation for biomedical research in the decades ahead
"They are among the Best Workers, Learning the Ways of a Vineyard Quickly": Aboriginal People, Drinking, and Labor in the Early Australian Wine Industry
This article considers historical instances of Aboriginal employment in Australian wine production in settler-colonial society, highlighting examples of the relationships created between Aboriginal and Italian-Australians. It challenges negative stereotypes that Aboriginal Australians were unable to control themselves in the presence of alcohol
Developing an Integrated Heads-Up Display for Astronauts
Gemstone Team VISORDuring extravehicular activities (EVAs), also known as spacewalks, astronauts are exposed
to the hazardous conditions of space. Therefore, they must accomplish tasks quickly and have easy
access to important information. This study aimed to investigate the effect of heads-up displays
(HUDs) on astronaut performance during a maintenance-focused EVA. We first compared usersā
completion times, comfort, and other factors while they performed operations on a task board using
audio instructions, using instructions on an off-the-shelf Microsoft HoloLens HUD, or using a
combination of the two. These tests showed a decrease in average mental demand as well as a
decrease in mean task completion time for the combined HoloLens and audio as compared to the
HoloLens or audio alone. Using these results, we designed and fabricated two versions of a display
integrated with an astronaut helmet: (1) a screen system mounted outside the helmet in the lower
right of the wearerās comfortable vision range and (2) a projector integrated into the structure of
the helmet that projects onto glass in the wearerās upper field of view. By making important task
information more accessible, our prototypes have the potential to increase astronaut safety by
decreasing the time they spend on EVAs. Results from testing show that users perform better with
and prefer a visual display in addition to audio communication. This means a visual display can
help reduce the duration of an EVA while keeping the user comfortable and focused
Broad-spectrum CRISPR-Cas13a enables efficient phage genome editing.
CRISPR-Cas13 proteins are RNA-guided RNA nucleases that defend against incoming RNA and DNA phages by binding to complementary target phage transcripts followed by general, non-specific RNA degradation. Here we analysed the defensive capabilities of LbuCas13a from Leptotrichia buccalis and found it to have robust antiviral activity unaffected by target phage gene essentiality, gene expression timing or target sequence location. Furthermore, we find LbuCas13a antiviral activity to be broadly effective against a wide range of phages by challenging LbuCas13a against nine E. coli phages from diverse phylogenetic groups. Leveraging the versatility and potency enabled by LbuCas13a targeting, we applied LbuCas13a towards broad-spectrum phage editing. Using a two-step phage-editing and enrichment method, we achieved seven markerless genome edits in three diverse phages with 100% efficiency, including edits as large as multi-gene deletions and as small as replacing a single codon. Cas13a can be applied as a generalizable tool for editing the most abundant and diverse biological entities on Earth
Recommended from our members
Novel anti-Sialyl-Tn monoclonal antibodies and antibody-drug conjugates demonstrate tumor specificity and anti-tumor activity
ABSTRACT Targeted therapeutics that can differentiate between normal and malignant tumor cells represent the ideal standard for the development of a successful anti-cancer strategy. The Sialyl-Thomsen-nouveau antigen (STn or Sialyl-Tn, also known as CD175s) is rarely seen in normal adult tissues, but it is abundantly expressed in many types of human epithelial cancers. We have identified novel antibodies that specifically target with high affinity the STn glycan independent of its carrier protein, affording the potential to recognize a wider array of cancer-specific sialylated proteins. A panel of murine monoclonal anti-STn therapeutic antibodies were generated and their binding specificity and efficacy were characterized in vitro and in in vivo murine cancer models. A subset of these antibodies were conjugated to monomethyl auristatin E (MMAE) to generate antibody-drug conjugates (ADCs). These ADCs demonstrated in vitro efficacy in STn-expressing cell lines and significant tumor growth inhibition in STn-expressing tumor xenograft cancer models with no evidence of overt toxicity
CRISPR-CasĪ¦ from huge phages is a hypercompact genome editor
CRISPR-Cas systems are found widely in prokaryotes, where they provide adaptive immunity against virus infection and plasmid transformation. We describe a minimal functional CRISPR-Cas system, comprising a single ~70-kilodalton protein, CasĪ¦, and a CRISPR array, encoded exclusively in the genomes of huge bacteriophages. CasĪ¦ uses a single active site for both CRISPR RNA (crRNA) processing and crRNA-guided DNA cutting to target foreign nucleic acids. This hypercompact system is active in vitro and in human and plant cells with expanded target recognition capabilities relative to other CRISPR-Cas proteins. Useful for genome editing and DNA detection but with a molecular weight half that of Cas9 and Cas12a genome-editing enzymes, CasĪ¦ offers advantages for cellular delivery that expand the genome editing toolbox
A call for transplant stewardship: The need for expanded evidenceābased evaluation of induction and biologicābased costāsaving strategies in kidney transplantation and beyond
Rising expenditures threaten healthcare sustainability. While transplant programs are typically considered profitable, transplant medications are expensive and frequently targeted for cost savings. This review aims to summarize available literature supporting costācontainment strategies used in solid organ transplant. Despite widespread use of these tactics, we found the available evidence to be fairly low quality. Strategies mainly focus on induction, particularly rabbit antithymocyte globulin (rATG), given its significant cost and the lack of consensus surrounding dosing. While there is higherāquality evidence for high singleādose rATG, and doseārounding protocols to reduce waste are likely low risk, more aggressive strategies, such as dosing rATG by CD3+ targetāattainment or on idealābodyāweight, have less robust support and did not always attain similar efficacy outcomes. Extrapolation of induction dosing strategies to rejection treatment is not supported by any currently available literature. Costāsaving strategies for supportive therapies, such as IVIG and rituximab also have minimal literature support. Deferral of highācost agents to the outpatient arena is associated with minimal risk and increases reimbursement, although may increase complexity and costāburden for patients and infusion centers. The available evidence highlights the need for evaluation of unique patientāspecific clinical scenarios and optimization of therapies, rather than simple blanket application of costāsaving initiatives in the transplant population.Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/170795/1/ctr14372_am.pdfhttp://deepblue.lib.umich.edu/bitstream/2027.42/170795/2/ctr14372.pd